Merck has FDA approval for a new combination drug for HIV, giving patients a new treatment option and an alternative to a blockbuster Gilead Sciences pill that comes with tolerability and side effect ...
Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...
The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the health regulator's website showed on Tuesday. The two-drug combination ...
In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus ...
Assoumou is an infectious diseases physician-scientist at Boston Medical Center. Miller is a research data associate within Dr. Assoumou’s I-CARE (Infectious Complications Assessment and Research) lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results